Viking Therapeutics
VKTX
$76.97
Share price
1.60%
Change (1 day)
255.19%
Change (1 year)
Categories
Earnings for Viking Therapeutics (VKTX)
Earnings in 2023 (TTM): -$85.9 M
According to Viking Therapeutics 's latest financial reports the company's current earnings (TTM) are -$93.72 M. In 2022 the company made an earning of -$68.87 M a decrease over its 2021 earnings that were of -$54.99 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Viking Therapeutics from 2014 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | -$85.9 M | 24.73% |
| 2022 | -$68.87 M | 25.24% |
| 2021 | -$54.99 M | 39.23% |
| 2020 | -$39.5 M | 53.21% |
| 2019 | -$25.78 M | 16.84% |
| 2018 | -$22.07 M | 7.22% |
| 2017 | -$20.58 M | 39.68% |
| 2016 | -$14.74 M | -37.05% |
| 2015 | -$23.41 M | 6.94% |
| 2014 | -$21.89 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Ultragenyx RARE | -$0.55 B | 478.81% | 🇺🇸 USA |
 Repligen
RGEN | $66.08 M | -170.51% | 🇺🇸 USA |
 Recro Pharma
REPH | $3.76 M | -104.02% | 🇺🇸 USA |